235 related articles for article (PubMed ID: 25306249)
1. The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes.
Carolan BJ; Hughes G; Morrow J; Hersh CP; O'Neal WK; Rennard S; Pillai SG; Belloni P; Cockayne DA; Comellas AP; Han M; Zemans RL; Kechris K; Bowler RP
Respir Res; 2014 Oct; 15(1):127. PubMed ID: 25306249
[TBL] [Abstract][Full Text] [Related]
2. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.
Pratte KA; Curtis JL; Kechris K; Couper D; Cho MH; Silverman EK; DeMeo DL; Sciurba FC; Zhang Y; Ortega VE; O'Neal WK; Gillenwater LA; Lynch DA; Hoffman EA; Newell JD; Comellas AP; Castaldi PJ; Miller BE; Pouwels SD; Hacken NHTT; Bischoff R; Klont F; Woodruff PG; Paine R; Barr RG; Hoidal J; Doerschuk CM; Charbonnier JP; Sung R; Locantore N; Yonchuk JG; Jacobson S; Tal-Singer R; Merrill D; Bowler RP
Respir Res; 2021 Apr; 22(1):127. PubMed ID: 33906653
[TBL] [Abstract][Full Text] [Related]
3. Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease.
Cheng DT; Kim DK; Cockayne DA; Belousov A; Bitter H; Cho MH; Duvoix A; Edwards LD; Lomas DA; Miller BE; Reynaert N; Tal-Singer R; Wouters EF; Agustí A; Fabbri LM; Rames A; Visvanathan S; Rennard SI; Jones P; Parmar H; MacNee W; Wolff G; Silverman EK; Mayer RJ; Pillai SG;
Am J Respir Crit Care Med; 2013 Oct; 188(8):948-57. PubMed ID: 23947473
[TBL] [Abstract][Full Text] [Related]
4. Plasma sRAGE levels strongly associate with centrilobular emphysema assessed by HRCT scans.
Klont F; Horvatovich P; Bowler RP; van Rikxoort E; Charbonnier JP; Kwiatkowski M; Lynch DA; Humphries S; Bischoff R; Ten Hacken NHT; Pouwels SD
Respir Res; 2022 Jan; 23(1):15. PubMed ID: 35073932
[TBL] [Abstract][Full Text] [Related]
5. A Genome-Wide Association Study of Emphysema and Airway Quantitative Imaging Phenotypes.
Cho MH; Castaldi PJ; Hersh CP; Hobbs BD; Barr RG; Tal-Singer R; Bakke P; Gulsvik A; San José Estépar R; Van Beek EJ; Coxson HO; Lynch DA; Washko GR; Laird NM; Crapo JD; Beaty TH; Silverman EK;
Am J Respir Crit Care Med; 2015 Sep; 192(5):559-69. PubMed ID: 26030696
[TBL] [Abstract][Full Text] [Related]
6. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.
Miniati M; Monti S; Basta G; Cocci F; Fornai E; Bottai M
Respir Res; 2011 Mar; 12(1):37. PubMed ID: 21450080
[TBL] [Abstract][Full Text] [Related]
7. Quantitative computed tomography measurements to evaluate airway disease in chronic obstructive pulmonary disease: Relationship to physiological measurements, clinical index and visual assessment of airway disease.
Nambu A; Zach J; Schroeder J; Jin G; Kim SS; Kim YI; Schnell C; Bowler R; Lynch DA
Eur J Radiol; 2016 Nov; 85(11):2144-2151. PubMed ID: 27776670
[TBL] [Abstract][Full Text] [Related]
8. The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study.
Coxson HO; Dirksen A; Edwards LD; Yates JC; Agusti A; Bakke P; Calverley PM; Celli B; Crim C; Duvoix A; Fauerbach PN; Lomas DA; Macnee W; Mayer RJ; Miller BE; Müller NL; Rennard SI; Silverman EK; Tal-Singer R; Wouters EF; Vestbo J;
Lancet Respir Med; 2013 Apr; 1(2):129-36. PubMed ID: 24429093
[TBL] [Abstract][Full Text] [Related]
9. Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease.
Schroeder JD; McKenzie AS; Zach JA; Wilson CG; Curran-Everett D; Stinson DS; Newell JD; Lynch DA
AJR Am J Roentgenol; 2013 Sep; 201(3):W460-70. PubMed ID: 23971478
[TBL] [Abstract][Full Text] [Related]
10. The association of adiponectin with computed tomography phenotypes in chronic obstructive pulmonary disease.
Carolan BJ; Kim YI; Williams AA; Kechris K; Lutz S; Reisdorph N; Bowler RP
Am J Respir Crit Care Med; 2013 Sep; 188(5):561-6. PubMed ID: 23777323
[TBL] [Abstract][Full Text] [Related]
11. Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung.
Yonchuk JG; Silverman EK; Bowler RP; Agustí A; Lomas DA; Miller BE; Tal-Singer R; Mayer RJ
Am J Respir Crit Care Med; 2015 Oct; 192(7):785-92. PubMed ID: 26132989
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of three-dimensional computed tomography-based radiologic phenotypes of chronic obstructive pulmonary disease.
Karayama M; Inui N; Yasui H; Kono M; Hozumi H; Suzuki Y; Furuhashi K; Hashimoto D; Enomoto N; Fujisawa T; Nakamura Y; Watanabe H; Suda T
Int J Chron Obstruct Pulmon Dis; 2019; 14():1333-1342. PubMed ID: 31296985
[TBL] [Abstract][Full Text] [Related]
13. Visual Emphysema at Chest CT in GOLD Stage 0 Cigarette Smokers Predicts Disease Progression: Results from the COPDGene Study.
Oh AS; Strand M; Pratte K; Regan EA; Humphries S; Crapo JD; Lynch DA;
Radiology; 2020 Sep; 296(3):641-649. PubMed ID: 32633676
[TBL] [Abstract][Full Text] [Related]
14. Validation of lung density indices by cardiac CT for quantification of lung emphysema.
Ronit A; Kristensen T; Çolak Y; Kühl JT; Kalhauge A; Lange P; Nordestgaard BG; Vestbo J; Nielsen SD; Kofoed KF
Int J Chron Obstruct Pulmon Dis; 2018; 13():3321-3330. PubMed ID: 30349236
[TBL] [Abstract][Full Text] [Related]
15. Quantifying the extent of emphysema: factors associated with radiologists' estimations and quantitative indices of emphysema severity using the ECLIPSE cohort.
Gietema HA; Müller NL; Fauerbach PV; Sharma S; Edwards LD; Camp PG; Coxson HO;
Acad Radiol; 2011 Jun; 18(6):661-71. PubMed ID: 21393027
[TBL] [Abstract][Full Text] [Related]
16. Relationships between diffusing capacity for carbon monoxide (DLCO), and quantitative computed tomography measurements and visual assessment for chronic obstructive pulmonary disease.
Nambu A; Zach J; Schroeder J; Jin GY; Kim SS; Kim YI; Schnell C; Bowler R; Lynch DA
Eur J Radiol; 2015 May; 84(5):980-5. PubMed ID: 25704753
[TBL] [Abstract][Full Text] [Related]
17. Radiographic Emphysema, Circulating Bone Biomarkers, and Progressive Bone Mineral Density Loss in Smokers.
Bon J; Zhang Y; Leader JK; Fuhrman C; Perera S; Chandra D; Bertolet M; Diergaarde B; Greenspan SL; Sciurba FC
Ann Am Thorac Soc; 2018 May; 15(5):615-621. PubMed ID: 29328885
[TBL] [Abstract][Full Text] [Related]
18. Association between emphysema-like lung on cardiac computed tomography and mortality in persons without airflow obstruction: a cohort study.
Oelsner EC; Hoffman EA; Folsom AR; Carr JJ; Enright PL; Kawut SM; Kronmal R; Lederer D; Lima JA; Lovasi GS; Shea S; Barr RG
Ann Intern Med; 2014 Dec; 161(12):863-73. PubMed ID: 25506855
[TBL] [Abstract][Full Text] [Related]
19. Computational analysis of thoracic multidetector row HRCT for segmentation and quantification of small airway air trapping and emphysema in obstructive pulmonary disease.
Barbosa EM; Song G; Tustison N; Kreider M; Gee JC; Gefter WB; Torigian DA
Acad Radiol; 2011 Oct; 18(10):1258-69. PubMed ID: 21893294
[TBL] [Abstract][Full Text] [Related]
20. Association between plasma sRAGE and emphysema according to the genotypes of AGER gene.
Sin S; Lim MN; Kim J; Bak SH; Kim WJ
BMC Pulm Med; 2022 Feb; 22(1):58. PubMed ID: 35144588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
